Universal Biosensors gets tested

The medical device maker’s shares suffered a jolt … but the prognosis remains strong.

Confidence in Universal Biosensors (UBI) is being tested. Shares in the company suffered their worst fall in nearly a year yesterday (Tuesday) when they tanked 10% following news that the company’s new product launch will be delayed until the first half of next year.

That isn’t the only dark cloud on the home medical testing device maker’s horizon, although attention is squarely focused on the fact that first commercial sales of its coagulation tester will not occur this year as originally thought.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles